@whitelist1
reply button wasn’t working
from memory when I did the math a while back, similar industry players CNQ and PWN have EVs around 2x and 4x revenue. Lower total revenue and faster cash burn. I have no experience in M&A or anything like that. I was once involved in the sale of a small insurance broker that was valued at 3.5x revenue but totally different industry and that company was also profitable so that makes a difference too. DEM seem to have a lot of recurring revenue and a path to growth that is coming to fruition (slower than I’d like). You no doubt have more experience in valuations than I do. I was just being relative to my own knowledge and research and thought a 2x revenue or more was realistic. Historically DEM has traded above 2x (3x?) as well. I might be being a bit amateur in my approach. Thanks for taking the time to reply.
- Forums
- ASX - By Stock
- DEM
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DEM (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $33.27M |
Open | High | Low | Value | Volume |
11.5¢ | 12.0¢ | 11.5¢ | $4.03K | 34.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 236645 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 23306 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 236645 | 0.110 |
5 | 157339 | 0.100 |
1 | 30303 | 0.099 |
2 | 110000 | 0.098 |
1 | 10500 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 23302 | 2 |
0.125 | 60213 | 1 |
0.130 | 206249 | 3 |
0.135 | 137499 | 2 |
0.140 | 175874 | 3 |
Last trade - 14.11pm 03/07/2024 (20 minute delay) ? |
Featured News
DEM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online